首页>
外国专利>
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
展开▼
机译:亲水性药物特别是低分子量肝素的口服药物剂型
展开▼
页面导航
摘要
著录项
相似文献
摘要
A delayed release pharmaceutical dosage form for oral administration of a hydrophilic drug, e.g., a polysaccharide drug such as low molecular weight heparin, are provided. The dosage form comprises a composition of: (a) a therapeutically effective amount of low molecular weight heparin; (b) a bile salt or bile acid; (c) at least one surfactant selected from hydrophilic surfactants, lipophilic surfactants, and mixtures thereof; and a means for delaying release of the composition from the dosage form following oral administration. Osmotic drug delivery systems for oral administration of a hydrophilic drug are also provided, wherein an osmotically activated device houses the drug, a bile salt or bile acid, and at least one surfactant selected from the group consisting of hydrophilic surfactants, lipophilic surfactants, and mixtures thereof. Methods for administering hydrophilic drugs, particularly polysaccharide drugs such as low molecular weight heparin, are also provided.
展开▼